chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started out with swelling & soreness at injection site.  About three days later the pain started in my left arm & it was a constant throbbing & was pretty bad.  Then came the upset stomach & could barely eat for days except for toast & some days I could tolerate peanut butter & maybe some crackers.  Really upset stomach.  Sneezing, blowing nose.  Dizzy.  Just plain feeling rotten most every day plus the brutal pain in my arm.  It's now the 28th of Sept & I am just starting to feel pretty normal again.  The pain in my arm lasted up until a few days ago when I noticed the swelling in my upper arm & started to ice it twice a day.  All in all, a horrible experience.  I got a double dose due to my age & that was the first mistake.....never again.
fever to 104.5, lethargy whimpering cry, hypotonic, some pallor began 24-36 hrs p/vax; initially low grade fever;
At 5:00pm, March 5th (7.5 hours after the jab) I suddenly got cold chills, nausea, and terrible headache. I eventually threw up. I hade joint aches and I couldn?t seem to get warm.   At 1:00am, March 6th after taking aspirin as directed on the label, my headache subsided and I felt famished and I felt like a new person.
No adverse effects were reported; Patient 18 years of age, inadvertently received PROQUAD; This spontaneous report was received from a nurse referring to a 18 year old patient of unknown gender. Information regarding the patient's concurrent conditions, past medical history, concomitant medications and drug reactions or allergies was not provided.  On 25-JUL-2019, the patient inadvertently received a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, lot # R024018 and expiration date 19-FEB-2020 (route and anatomical location were not reported), for prophylaxis (product administered to patient of inappropriate age). The vaccine was administered using a sterile diluent (lot # S007959 and expiration date 19-AUG-2021). No adverse effects were reported.
Within past month, mother has observed rapid acceleration and violent behavior at school. Prior to that, he had done fairly well for 2 months. The patient is on no medications. He has been tackling other children at school and reportedly told his mother "fighting is exciting." He has had progressively lowering threshold for attacking other children. His mother had picked him up from school on a Wednesday, kept him out the following day. When he returned to school, his mother again had to pick him up only after an hour. His mother noted development of increasing violent behavior after his polio vax.
Patients received expired doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059h21a) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2022: Follow up document contain secondary reporter, patient name, DOB, age gender, VAERS confirmation numbers and date of administration were updated
Patient arm that received the PNEUMOVAX shot was completely swollen from shoulder to fingers and red. Patient stated swelling started last evening and has progressed through the evening. Patient stated was unable to lift arm without pain. Other arm flu shot was given in was not affected. No trouble breathing or tongue swelling per patient. Referred patient to go to urgent care so they could look at her arm
Patient felt tired and not well beginning on 10/29/2017. Experienced sharp pain behind right eye on 10-31-17. She couldn't open her eye and severe headache. 2 to 3 weeks of extreme fatigue. Has seen 5 doctors. DX: microvascular incident, paralysis of 3rd craninal nerve. Has double vision.
Localized injection site redness and soreness.  Approximately 5" diamater area of redness, swelling and warm to the touch.  Indicative of a skin infection.
Awoke at 8 a.m. on Thursday. 0311/2021, to find a lot of blood on gown, bedding, and face, coming from left nostril constantly.  I don't know how long it had been going on.  Kept pressing nostril for about 30 minutes, bleeding didn't stop.  I got an ice pack and pressed against nose for 20 minutes, did this off and on 3 times and bleeding finally slowed down and stopped at about 11:00 a.m.  There have been no problems since.  I have had very few nosebleeds due to dry air and they have been short and light.  I have never had one like this.  I don't know when it started during the night but ended about 11 a.m.  There was a already a lot of blood by 8 a.m.  My daughter thought such a rare event might be connected to the vaccine and that I  should report  it.
Patient reported "heavy and hot flashes" in her head, "hot flashes" in her ears, nasal congestion and feeling  generalized "hotness" in her body about 30 minutes after vaccine administration.  HR 74. Denied any SOB or dizziness.
tacchycardia, High blood pressue, redness on vaccine arm, mild flushing
Patient tested positive to COVID-19; a little soreness in the site of injection; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (a little soreness in the site of injection) and COVID-19 (Patient tested positive to COVID-19) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 037K20A) for COVID-19 vaccination.     The patient's past medical history included GERD (Intestinal reflux). Concurrent medical conditions included Seasonal allergy, Diabetes, Cholesterolosis NOS, Asthma (Acute asthma), Drug allergy (diabetic medications) and Drug allergy (cholesterol medications).   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (a little soreness in the site of injection). On 14-Sep-2022, the patient experienced COVID-19 (Patient tested positive to COVID-19). The patient was treated with AZITHROMYCIN for COVID-19, at an unspecified dose and frequency. On 07-Nov-2021, VACCINATION SITE PAIN (a little soreness in the site of injection) had resolved. On 19-Sep-2022, COVID-19 (Patient tested positive to COVID-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Sep-2022, SARS-CoV-2 test: (Positive) Positive. On 19-Sep-2022, SARS-CoV-2 test: (Negative) Negative.         Patient did not take other vaccines within one month prior to Moderna COVID-19 vaccine. Patient stated she was under a lot of regular and concomitant medications which also included diabetic medications and cholesterol medications. It was reported that AE cause patient to seek medical care. Patient does not experienced a similar event in the past.
Patient felt a slight dryness in back of throat after a few moments admin and as if there was a small pill stuck in throat. Also felt some itching sensation at injection site. Upon examining site, some slight redness and swelling was present. Patient drank some H2O and said felt same or slightly better and itching was minimal. Upon questioning, patient had no other sx such as SOB, lightheaded dizzy etc. Called MD said go to ER, patient refused, took BENADRYL and went home. Called 2 hrs later and said was fine.
About two weeks post-booster started experiencing areas of intense itching all over body.  Areas of itching will migrate, mostly on back of neck and torso, as well as hands and arms.  Small papules will appear and rash area will develop, then severe erythema.  On daily dose of Zyrtec and using Triamcinolone lotion on hand and arm areas of itchiness.  Symptoms improve with Zyrtec, but have never resolved.
This spontaneous report as received from a pharmacist via company representative refers to a patient of unknown age and gender. The patient's medical history and concurrent condition were not reported. The pharmacist reported that prior to receiving ZOSTAVAX the patient had developed 3 bumps on his back which they thought were bug bites. On 09-OCT-2015 the patient was vaccinated with a dose of ZOSTAVAX (lot#, strength, dose and route were not reported). On an unspecified day, in October 2015 the patient developed 3 more bumps on his chest that were red. The pharmacist, at the time of report, thought that the patient might had an active case of shingles prior to getting the ZOSTAVAX. The outcome of the patient's events was not reported. The relatedness between the vaccination with ZOSTAVAX and the patient's events was not reported. Additional information has been requested.
Chills, muscle aches throughout body, injection site very sore for several days, large red blotch around injection site which was hot to the touch, fatigue
Headache; scratchy throat; This is a spontaneous report from a contactable consumer. A 65-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL1283), via an unspecified route of administration on 15Jan2021 at single dose on left arm for COVID-19 immunisation. Medical history included blood pressure high, thyroid disorder and mental health disorder. Concomitant medication included took one medication for high blood pressure and a thyroid medication, both of those have been diagnosed quite a while and she had been on those medications a while. Patient was also on a mental health medication as well.  Patient had a headache Tuesday (19Jan2021) or Wednesday (20Jan2021) this week. Patient also had a really scratchy throat. She didn't know if that was related to bnt162b2 or not. Treatment included ibuprofen (ADVIL 200mg, lot: R88356, expiration date: May2023). Patient took two 200mg, no more than every 4 hours or something, then clarified that patient took a couple at nighttime. Headache hadn't gotten worse. It was not as bad today (22Jan2021). It seemed to be subsiding. Outcome of headache was resolving. Outcome of scratchy throat was unknown.
Sore Throat; Fever - Temperature of 103.0F; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat) and PYREXIA (Fever - Temperature of 103.0F) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat) and PYREXIA (Fever - Temperature of 103.0F). The patient was treated with PREDNISONE at an unspecified dose and frequency. On 07-Mar-2021, OROPHARYNGEAL PAIN (Sore Throat) and PYREXIA (Fever - Temperature of 103.0F) had resolved. Not Provided          No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the event was not applicable.
with the 1st shot she didn't feel great; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient received BNT162b2 (BNT162B2), on 18Mar2021 as dose 1, single (Lot number: EP7534) at the age of 63 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Levothyroxine, notes: 75mcg once a day; Bupropion hydrochloride, notes: 300mg once a day; Clonazepam, notes: 1mg once a day. The following information was reported: FEELING ABNORMAL (non-serious) with onset 12Jun2022, outcome "not recovered", described as "with the 1st shot she didn't feel great". Additional information- She noticed the horrible taste in her mouth pretty quickly, she started the Paxlovid Friday and noticed the taste Saturday, she did not recall what time of day. States she was counting the days until she was off the stuff. Started Paxlovid afternoon dose on Friday 10Jun2022. States the box calls them tablets but she would say they were capsules. It was reported that, she also lost her appetite a bit and did not know if that was from not feeling well or not. She noticed that this Sunday for sure, it is persisting, got a bit worse and she did not know if it's linked to the taste in her mouth. She takes Wellbutrin, Bupropion Hydrochloride and she thought it's supposed to give a bump of energy and she has not noticed that. She was a teacher so she was medicated.  No follow-up attempts are needed. No further information is expected.
A temperature 101 fever; Tongue felt different/ Not severe tongue issue; Tongue felt a bit bigger; Tongue color is greyish; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Tongue felt different/ Not severe tongue issue), SWOLLEN TONGUE (Tongue felt a bit bigger), TONGUE PIGMENTATION (Tongue color is greyish) and PYREXIA (A temperature 101 fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PARAESTHESIA ORAL (Tongue felt different/ Not severe tongue issue), SWOLLEN TONGUE (Tongue felt a bit bigger) and TONGUE PIGMENTATION (Tongue color is greyish). On 14-Feb-2021, the patient experienced PYREXIA (A temperature 101 fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 13-Feb-2021 for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA ORAL (Tongue felt different/ Not severe tongue issue), SWOLLEN TONGUE (Tongue felt a bit bigger), TONGUE PIGMENTATION (Tongue color is greyish) and PYREXIA (A temperature 101 fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Body temperature: 101 High.         No concomitant medication was reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Additional information was added: Event outcome were updated from unknown to recovered as patient reported she is doing fine and declined consent for further follow up
Redness, warmth, swelling at site of left thigh, where DTaP/IPV given.
On 1/25/00,pt recv'd Varivax & MMR vax.On 2/2/00, pt dvlped respiratory symptoms w/ fever.On 2/5/00, pt fell from bed;parents noticed he was not moving arm so took him to ER where he was dxed w/ a soft tissue injury.On 2/6/00, pt returned. 60 day follow-up dated 6/29/00 states the quadriparesis is showing gradual improvement, diaphragmatic paralysis.
Several minutes after vaccine given, individual c/o feeling weird and having "a strange taste in her mouth"; she also c/o some itchiness and her right arm feeling heavy.  Denied difficulty breathing, palpitations.  No other specific s/sx and reported sensitivities to many things and has previously reacted when taking other medications.  Denied difficulty breathing; declined medical evaluation at that time; took Benadryl 25mg by mouth; instructed to report worsening s/sx.  At around 1640, individual reported significant worsening of s/sx, "feeling really bad, continued strange taste in mouth, dry mouth, flushing/hot flashes and itching all over".  Left ear reddened, right ear not; no rash visualized elsewhere but due to worsening s/sx taken to ED for evaluation and treatment.
AT INJECTION SITE.  ONSET 24 HOURS AFTER INJECTION.  PATIENT REPORTED: RAISED, SWOLLEN, HARD, RED AREA. AREA SORE AND CAUSING MILD-MODERATE PAIN AND DISCOMFORT. DESCRIBED SWOLLEN AREA AS THE SIZE OF SMALL ORANGE OR LEMON. DURATION 2 DAYS. NOT RESOLVED YET.
STATES SHE BROKE OUT W/SHINGLES ON HER FACE 7 - 10 DAYS AFTER VACCINE. SHE SAID THIS WAS DIAGNOSED BY HER PHYSICIAN. CALL TO REPORT THIS ON 3/21/08.
1220: it was noted on my schedule that patient made appt. At 2:30 for numbness, tingling, and color/temp change of LUE.  I had staff call her to come down to clinic immediately for assessment given she is post Pneumococcal vaccination to the left deltoid.  Upon arrival, she is in no acute distress, tolerated the walk to the clinic without difficulty.  No audible wheezing nor stridor.  Assessment of LUE reveals intact CMS, cap. Refill < 2 sec. , and normal ROM.  LUE does have minor soft tissue swelling from deltoid area down to left forearm, brachial and radial pulses intact.  She does have some tenderness with palpation of the brachial pulse.  No cervical lymph swelling noted.  Lungs are CTA bilaterally.  She does have history of similar vaccination reaction.  Does not have such reaction to influenza vaccinations.  SouMedrol IM and Benadryl IM given as ordered.  Patient tolerated well and stable after injections.  Able to RTW without difficulty.  It is noted upon further chart review, her COVID vaccination and the Pneumococcal vaccination both are Pfizer-manufactured.  Her influenza vaccinations have historically been manufactured by Sanofi Pasteur or Seqirus.
After flu vaccination patient states she felt dizzy, nauseous, and had an itchy throat and briefly had rapid heart beat. When assessed not obvious signs of distress. Vital signs were checked by nurse and also had an increased intake of water and food.
9 days p/vax had fine red rash (pin point) feels like sugar;no other s/s;
Severe headache and body aches. Worse than any influenza I?ve ever had in my entire life.
Having trouble getting dressed; ache / cant use my shoulder; muscle has been very very sore; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Having trouble getting dressed), ARTHRALGIA (ache / cant use my shoulder) and MYALGIA (muscle has been very very sore) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Having trouble getting dressed), ARTHRALGIA (ache / cant use my shoulder) and MYALGIA (muscle has been very very sore). At the time of the report, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Having trouble getting dressed) outcome was unknown and ARTHRALGIA (ache / cant use my shoulder) and MYALGIA (muscle has been very very sore) had not resolved.            No concomitant medication information was provided by the reporter.  No treatment information was  provided.; Sender's Comments: Non-serious Case
This spontaneous report as received from a consumer refers to a currently 70-year-old, elderly, male patient. The patient's concurrent conditions included chronic obstructive pulmonary disease (COPD), high blood pressure, being immunocompromised and overweight, abdominal aortic aneurysm endoleak and drug allergy to tetracycline, hydroxychloroquine sulfate (PLAQUENIL), unspecified iron and nickel. On an unknown date, reported as "since it came out, even before the 23 version came out", the patient was getting PNEUMOVAX 23 (dose, route of administration, lot # and expiration date were not reported) and was revaccinated with it once every five years since then. He had also routinely been vaccinated then revaccinated with PREVNAR 13 on an unspecified schedule. In approximately 2013 (reported as "a few months after he turned 65-year-old"), the patient was vaccinated with his last PNEUMOVAX 23 injection, in his arm, for prevention of pneumococcal disease (exact dose, frequency, route of administration, lot# and expiration date were unknown). Concomitant therapies included irbesartan (AVAPRO), metoprolol succinate (TOPROL XL), baby aspirin, warfarin sodium (COUMADIN), terazosin, tiotropium bromide (SPIRIVA), fluticasone furoate (+) vilanterol trifenatate (BREO) and rosuvastatin calcium (CRESTOR). On an unknown date in May 2018, the patient was admitted to hospital for multifocal pneumonia. He was released from the hospital one week later. According to the reporter, X-ray, CAT, complete blood count (CBC), basic metabolic tests, international normalized ratio (INR) test, all of the required tests when someone got pneumonia were performed. The patient sought medical attention. Treatment was given for the adverse event. On an unspecified date in 2018, the patient recovered from the multifocal pneumonia after he left the hospital. The causality assessment was not provided. Upon internal review, the event of multifocal pneumonia was determined as medically significant.
Feels like I have a cold; Feel run down; Nasal congestion; Feel very tired; Sore throat; Wasn't feeling well; This spontaneous case was received on 02-Nov-2022 from other non-health professional (consumer) via Med Communications (reference number: SEQW22-05313) and concerned a 62-year-old female patient.  The patient's medical history was not reported. The patient's concomitant medications included lisinopril and hydrochlorothiazide (reported as HCT), both used for unreported indication. The patient stated that she was healthy person.  On 28-Oct-2022, the patient was vaccinated with influenza vaccine (brand not specified; dose, route of administration and anatomical location: not reported) as active immunization for the prevention of influenza disease. The batch number was not reported.  On 31-Oct-2022, three days after receiving influenza vaccine, the patient felt unwell and was very tired, also developed nasal congestion, felt run down and developed sore throat. The patient also reported she felt like she had a cold. The patient took her temperature and said she didn't have a fever.  At the time of initial reporting, on 02-Nov-2022, the patient had not recovered from the events.  The reporter assessed events as related to influenza vaccine. As it was reported this was the first-time reporter ever had a reaction to o flu shot.  The case was assessed as non-serious.  Company comment: A 62-year-old patient experienced nasopharyngitis, asthenia, nasal congestion, fatigue, oropharyngeal pain, and malaise three days after receiving the suspect product influenza vaccine. Based on plausible temporal relationship, causality for the reported events is assessed as possibly related.; Reporter's Comments: As it was reported this was the first-time reporter ever had a reaction to o flu shot.; Sender's Comments: A 62-year-old patient experienced nasopharyngitis, asthenia, nasal congestion, fatigue, oropharyngeal pain, and malaise three days after receiving the suspect product influenza vaccine. Based on plausible temporal relationship, causality for the reported events is assessed as possibly related.